Google News • 1/11/2026 – 1/13/2026
The JP Morgan conference is considered important for healthcare dealmakers, who are heading to San Francisco with hopes for megamergers in 2026. However, it is noted that the conference is not make-or-break for the industry. Recent reports indicate a decline in stock performance, attributed to a lack of deal news, while EY predicts a surge in mergers and acquisitions but sluggish initial public offerings in 2026.
Advertisement
Stories gain Lindy status through source reputation, network consensus, and time survival.


